VERAPAMIL THERAPY - NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .2. EFFECTS ON EXERCISE CAPACITY AND SYMPTOMATIC STATUS

被引：202
|
作者：
ROSING, DR
KENT, KM
MARON, BJ
EPSTEIN, SE
机构：
来源：
CIRCULATION | 1979年 / 60卷 / 06期
关键词：
D O I：
10.1161/01.CIR.60.6.1208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1208 / 1213
页数：6
相关论文
共 12 条
  • [1] VERAPAMIL THERAPY - A NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
    ROSING, DR
    KENT, KM
    MARON, BJ
    CONDIT, J
    EPSTEIN, SE
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1980, 3 (1-2): : 195 - 203
  • [2] VERAPAMIL THERAPY - A NEW APPROACH TO PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
    ROSING, DR
    KENT, KM
    MARON, BJ
    CONDIT, J
    EPSTEIN, SE
    [J]. CHEST, 1980, 78 (01) : 239 - 247
  • [3] VERAPAMIL THERAPY - NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .1. HEMODYNAMIC-EFFECTS
    ROSING, DR
    KENT, KM
    BORER, JS
    SEIDES, SF
    MARON, BJ
    EPSTEIN, SE
    [J]. CIRCULATION, 1979, 60 (06) : 1201 - 1207
  • [4] EFFECTS OF VERAPAMIL ON EXERCISE CAPACITY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    ROSING, DR
    KENT, KM
    MARON, BJ
    EPSTEIN, SE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1979, 43 (02): : 398 - 398
  • [5] VERAPAMIL THERAPY - A NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .3. EFFECTS OF LONG-TERM ADMINISTRATION
    ROSING, DR
    CONDIT, JR
    MARON, BJ
    KENT, KM
    LEON, MB
    BONOW, RO
    LIPSON, LC
    EPSTEIN, SE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (03): : 545 - 553
  • [6] VERAPAMIL - NEW APPROACH TO THE TREATMENT OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    ROSING, DR
    CONDIT, J
    MARON, BJ
    KENT, KM
    EPSTEIN, SE
    [J]. CIRCULATION, 1979, 60 (04) : 155 - 155
  • [7] COMPARISON OF VERAPAMIL AND NIFEDIPINE EFFECTS ON SYMPTOMS AND EXERCISE CAPACITY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    ROSING, DR
    CANNON, RO
    WATSON, RM
    KENT, KM
    LAKATOS, E
    EPSTEIN, SE
    [J]. CIRCULATION, 1982, 66 (04) : 24 - 24
  • [8] ARRHYTHMIA IN HYPERTROPHIC CARDIOMYOPATHY .2. COMPARISON OF AMIODARONE AND VERAPAMIL IN TREATMENT
    MCKENNA, WJ
    HARRIS, L
    PEREZ, G
    KRIKLER, DM
    OAKLEY, C
    GOODWIN, JF
    [J]. BRITISH HEART JOURNAL, 1981, 46 (02): : 173 - 178
  • [9] Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial
    Olivotto, Iacopo
    Hellawell, Jennifer L.
    Farzaneh-Far, Ramin
    Blair, Christiana
    Coppini, Raffaele
    Myers, Jonathan
    Belardinelli, Luiz
    Maron, Martin S.
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (03)
  • [10] Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy
    Bratt, Ewa-Lena
    Ostman-Smith, Ingegerd
    [J]. CARDIOLOGY IN THE YOUNG, 2015, 25 (03) : 501 - 510
12